Eradication of Prostate Cancer Using F-989

Optimal Health Research

Status and phase: Completed; Phase 2

Conditions: Prostate Cancer

Treatments: Dietary Supplement: Acetogenins

Study type: Interventional

Funder types: Other

Identifiers

NCT01987999

F-9892131

Details and patient eligibility

About

The purpose of this study is to confirm the findings of an early study with prostate cancer and to expand our knowledge of treating prostate cancer using F-989.

Enrollment: 60 patients

Sex: Male

Ages: 40 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of prostate cancer
• Referred to the study by their treating physician

Exclusion criteria

• Any type of treatment before starting study

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

Acetogenins

Experimental group

Description:

Acetogenins twice (BID) per day for 12 months

Treatment:

Dietary Supplement: Acetogenins